Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Bruker Corporation is a medical devices business based in the US. Bruker Corporation shares (BRKR) are listed on the NASDAQ and all prices are listed in US Dollars. Bruker Corporation employs 7,400 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$77.23|
|52-week range||$40.47 - $92.35|
|50-day moving average||$82.91|
|200-day moving average||$76.37|
|Wall St. target price||$84.36|
|Dividend yield||$0.16 (0.21%)|
|Earnings per share (TTM)||$1.55|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||0.09%|
|1 month (2021-09-17)||-7.34%|
|3 months (2021-07-16)||-1.44%|
|6 months (2021-04-16)||14.16%|
|1 year (2020-10-16)||83.05%|
|2 years (2019-10-17)||76.97%|
|3 years (2018-10-17)||138.22%|
|5 years (2016-10-17)||262.92%|
Valuing Bruker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bruker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bruker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 50x. In other words, Bruker Corporation shares trade at around 50x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bruker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.64. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bruker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bruker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $476.8 million.
The EBITDA is a measure of a Bruker Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.3 billion|
|Operating margin TTM||17.25%|
|Gross profit TTM||$944.4 million|
|Return on assets TTM||8.1%|
|Return on equity TTM||25.29%|
|Market capitalisation||$11.7 billion|
TTM: trailing 12 months
There are currently 1.8 million Bruker Corporation shares held short by investors – that's known as Bruker Corporation's "short interest". This figure is 60.2% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting Bruker Corporation shares can be evaluated.
Bruker Corporation's "short interest ratio" (SIR) is the quantity of Bruker Corporation shares currently shorted divided by the average quantity of Bruker Corporation shares traded daily (recently around 718426.98412698). Bruker Corporation's SIR currently stands at 2.52. In other words for every 100,000 Bruker Corporation shares traded daily on the market, roughly 2520 shares are currently held short.
However Bruker Corporation's short interest can also be evaluated against the total number of Bruker Corporation shares, or, against the total number of tradable Bruker Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bruker Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Bruker Corporation shares in existence, roughly 10 shares are currently held short) or 0.0178% of the tradable shares (for every 100,000 tradable Bruker Corporation shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bruker Corporation.
Find out more about how you can short Bruker Corporation stock.
Dividend payout ratio: 10.32% of net profits
Recently Bruker Corporation has paid out, on average, around 10.32% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bruker Corporation shareholders could enjoy a 0.21% return on their shares, in the form of dividend payments. In Bruker Corporation's case, that would currently equate to about $0.16 per share.
While Bruker Corporation's payout ratio might seem low, this can signify that Bruker Corporation is investing more in its future growth.
Bruker Corporation's most recent dividend payout was on 16 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 August 2021 (the "ex-dividend date").
Over the last 12 months, Bruker Corporation's shares have ranged in value from as little as $40.4701 up to $92.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bruker Corporation's is 1.3053. This would suggest that Bruker Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.